BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16825878)

  • 21. Octreotide treatment of chylothorax in pediatric patients following cardiothoracic surgery.
    Caverly L; Rausch CM; da Cruz E; Kaufman J
    Congenit Heart Dis; 2010; 5(6):573-8. PubMed ID: 21106017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin - therapeutic option for chylothorax in preterm neonates. Report on two patients and review of the literature.
    Jochum F; Nomayo A; Hentschel R; Leuchter M; Fusch Ch
    Georgian Med News; 2011 Apr; (193):69-76. PubMed ID: 21617279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yellow nail syndrome: treatment with octreotide.
    Hillerdal G
    Clin Respir J; 2007 Dec; 1(2):120-1. PubMed ID: 20298292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin treatment of massive lymphorrhea following excision of a lymphatic malformation.
    Suver DW; Perkins JA; Manning SC
    Int J Pediatr Otorhinolaryngol; 2004 Jun; 68(6):845-50. PubMed ID: 15126030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.
    Roehr CC; Jung A; Proquitté H; Blankenstein O; Hammer H; Lakhoo K; Wauer RR
    Intensive Care Med; 2006 May; 32(5):650-7. PubMed ID: 16532329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Dose Intravenous Octreotide Is Safe and May Be Superior to Surgery in Managing Severe Postesophagectomy Chylothorax in High-Risk Patients.
    Bello SO; Rahamim J
    Ann Thorac Surg; 2015 Jul; 100(1):297-9. PubMed ID: 26140770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of a persistent postoperative chylothorax with octreotide].
    Miura K; Ono H; Endou H; Nagata T; Kougo M; Oono M; Andou T; Murakami H; Kobayashi T; Chikada M; Makuuchi H
    Kyobu Geka; 2009 Sep; 62(10):885-7. PubMed ID: 19764494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative chylothorax after cardiothoracic surgery in children.
    Chan EH; Russell JL; Williams WG; Van Arsdell GS; Coles JG; McCrindle BW
    Ann Thorac Surg; 2005 Nov; 80(5):1864-70. PubMed ID: 16242470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The successful use of octreotide in the treatment of traumatic chylothorax.
    Sharkey AJ; Rao JN
    Tex Heart Inst J; 2012; 39(3):428-30. PubMed ID: 22719161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chylothorax after surgery for congenital heart disease.
    Zuluaga MT
    Curr Opin Pediatr; 2012 Jun; 24(3):291-4. PubMed ID: 22498675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nutritional support and treatment of chylothorax with octreotide].
    Sirvent Ochando M; López Villodre P; Martínez Seguí MJ
    Nutr Hosp; 2010; 25(1):113-9. PubMed ID: 20204265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chylothorax: diagnosis and management in children.
    Soto-Martinez M; Massie J
    Paediatr Respir Rev; 2009 Dec; 10(4):199-207. PubMed ID: 19879510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report.
    Sivasli E; Dogru D; Aslan AT; Yurdakok M; Tekinalp G
    J Perinatol; 2004 Apr; 24(4):261-2. PubMed ID: 15067298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octreotide therapy in two children with intractable postoperative chylothorax.
    Hung WP; Wang JN; Chang HK; Wu JM
    Int J Cardiol; 2011 Feb; 146(3):e63-5. PubMed ID: 19193452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of octreotide to treat congenital chylothorax.
    Paget-Brown A; Kattwinkel J; Rodgers BM; Michalsky MP
    J Pediatr Surg; 2006 Apr; 41(4):845-7. PubMed ID: 16567206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of chylothorax in a premature infant using somatostatin.
    Goto M; Kawamata K; Kitano M; Watanabe K; Chiba Y
    J Perinatol; 2003 Oct; 23(7):563-4. PubMed ID: 14566354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postoperative refractory chylothorax which was improved by octreotide acetate].
    Gabe A; Seki M; Taira N; Katsura M; Ishida T; Kang Y; Kubota T; Yamashiro T; Uehara T; Sunagawa T; Ohkubo K
    Kyobu Geka; 2012 Mar; 65(3):230-3. PubMed ID: 22374601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Octreotide, a somatostatin analogue, in the treatment of chylothorax associated with idiopathic fibrosing mediastinitis.
    Togashi Y; Kim YH; Miyahara R; Irisa K; Sakamori Y; Masago K; Mio T; Date H; Mishima M
    Tohoku J Exp Med; 2010 Sep; 222(1):51-3. PubMed ID: 20814178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology and management of chylothorax following pediatric heart surgery.
    Milonakis M; Chatzis AC; Giannopoulos NM; Contrafouris C; Bobos D; Kirvassilis GV; Sarris GE
    J Card Surg; 2009; 24(4):369-73. PubMed ID: 19583606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide.
    Matsukuma E; Aoki Y; Sakai M; Kawamoto N; Watanabe H; Iwagaki S; Takahashi Y; Kawabata I; Kondo N; Uchida Y
    J Pediatr Surg; 2009 Mar; 44(3):e37-9. PubMed ID: 19302843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.